Elma Hawkins

President, CEO, and Co-Founder, Redpin Therapeutics Inc.

Elma-HawkinsDr. Hawkins’ 30-year career encompasses pioneering efforts in biotechnology drug development and executive roles in corporate development, strategy, fund raising, and general management. Her therapeutic expertise is in oncology, infectious diseases and wound healing. She served as the President and Chief Operating Officer at Lion Biotechnologies. Previously, as President of Cerulean BioVentures, she provided counsel to biotechnology companies, hedge funds, and private equity firms. She is also President and CEO of Viridian Pharmaceuticals. Prior to her current positions, Dr. Hawkins was Vice Chairman of Antigenics and later President and CEO of Advanced Viral Research. At Genzyme Corporation, she was Director of Corporate Development. Dr. Hawkins’ career followed multiple academic degrees: BSc in Mathematics and Chemistry, BSc (Hons) in Chemistry, MSc in Organic Chemistry, a PhD in Organic Chemistry and an MBA with specialization in entrepreneurship.